10.4% of XBI Holdings Seeing Recent Insider Buys
September 12, 2014 at 09:41 AM EDT
A look at the weighted underlying holdings of the SPDR S&P Biotech ETF (XBI) shows an impressive 10.4% of holdings on a weighted basis have experienced insider buying within the past six months. Start slideshow:10 ETFs With Stocks That Insiders Are Buying Aegerion Pharmaceuticals Inc (AEGR), which makes up 1.19% of the SPDR S&P Biotech ETF (XBI), has seen 3 directors and officers purchase shares in the past six months, according to the recent Form 4 data.